Targeted therapies are designed to "target" specific proteins or genes that may be responsible for cancer cell growth and survival.
First, this lecture will discuss the differences between chemotherapy, immunotherapy and targeted therapy.
Then, we will review different therapies that are used to "target" common proteins or genes, such as HER2, VEGF, PARP, and CD20. Finally, there will be an opportunity for patients to ask questions about their targeted therapies. This lecture will be facilitated by Rose DiMarco, PharmD, BCPS, BCOP.